Similarly, a biodistribution study of [18F]AlF-NOTA-FAPI-04 demonstrated high specificity for FAP binding to FAP in vitro and in vivo, both on the human U87 cancer cell line (glioblastoma) and in 28 patients with various cancers (lung, pancreatic, and sarcoma). This evidence concerns the gene FAP and glioblastoma.